Related Experiment Video
Updated: Dec 28, 2025

Author Spotlight: Deciphering the Long-Term Effects of Low-Level Blast Exposures in Mice
Published on: May 24, 2024
Evaluation of Blast Overpressure Exposure Effects on Concentration of Antibiotics in Mice
Vlado Antonic1,2, Venkatasivasaisujith Sajja3, Jason Sousa4
1CCCRP, 722 Doughten Street, Fort Detrick, MD 21702.
Objective:
Infection as sequelae to explosion-related injury is an enduring threat to our troops. There are limited data on the effects of blast on antibiotic pharmacokinetics (PK), pharmacodynamics (PD), and efficacy. The observational study presented here is our Institute's first attempt to address this issue by combining our existing interdepartmental blast, infection modeling, and in vivo PK/PD capabilities and was designed to determine the PK effects of blast on the first-line antibiotic, cefazolin, in an in vivo mouse model.
Methods:
A total of 160 male BALB/c mice were divided to sham and blast (exposed to blast overpressure of 19 psi) in two biological replicates. At 1 hour after blast/sham exposure, the animals received IV injection of cefazolin (328 mg/kg). Animals were euthanized at 3 minutes, 10 minutes, 15 minutes, 30 minutes, 1 hour, 3 hours, 6 hours, or 10 hours after the injection. Plasma and liver were analyzed for concentration of cefazolin using mass-spectrometry.
Results:
We observed increases in the concentration of cefazolin in the plasma and liver of blast exposed animals at later time points and increase in elimination half-life.
Conclusion:
Our results indicate that blast-induced physiologic changes significantly influence cefazolin PK and suggest that efficacy could be affected in the context of the blast; assessment of efficacy and PD effects require further investigation. Metabolic changes resulting from blast may influence other classes of antibiotics and other therapeutics used with these injuries. Therefore, this may have important treatment considerations in other areas of military medicine.
Insights
Blast exposure alters cefazolin pharmacokinetics (PK) in mice, increasing drug concentration and half-life. These findings suggest potential impacts on antibiotic efficacy for blast-injured individuals.
Area of Science:
- Military Medicine
- Pharmacology
- Trauma Research
Background:
- Infection is a significant risk following explosion-related injuries.
- Limited data exist on how blast exposure affects antibiotic pharmacokinetics (PK), pharmacodynamics (PD), and efficacy.
- Understanding these effects is crucial for optimizing treatment in military personnel.
Purpose of the Study:
- To investigate the impact of blast exposure on the PK of cefazolin, a first-line antibiotic.
- To establish an in vivo mouse model combining blast, infection, and PK/PD capabilities.
- To determine how blast exposure influences cefazolin concentrations and elimination in plasma and liver.
Main Methods:
- 160 male BALB/c mice were divided into sham and blast-exposed groups (19 psi).
- Cefazolin was administered intravenously 1 hour post-exposure.
- Plasma and liver samples were collected at various time points for cefazolin concentration analysis via mass spectrometry.
Main Results:
- Blast-exposed mice showed increased cefazolin concentrations in plasma and liver at later time points.
- An increased elimination half-life of cefazolin was observed in blast-exposed animals.
- These results indicate significant alterations in cefazolin PK due to blast exposure.
Conclusions:
- Blast-induced physiological changes significantly affect cefazolin PK.
- The findings suggest that antibiotic efficacy may be compromised in blast-injured patients.
- Further research is needed to assess efficacy and PD effects, with implications for military medicine treatment strategies.
More Related Videos
08:33Quantitative Polymerase Chain Reaction-based Analyses of Murine Intestinal Microbiota After Oral Antibiotic Treatment
Published on: November 17, 2018
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017